top of page
PASSRACGP Logo_white.png

Progress

0%

Cardiovascular

Tinea


Typical appearance: Annular/scaly lesion with well-defined edge, central clearing, ± pruritus/inflammation


Clinical Presentations

  • Tinea pedis (feet) – Most common in adults

    • Maceration in toe webs, vesicles, or diffuse sole scaling

    • Often coexists with tinea cruris or onychomycosis

  • Tinea cruris (groin)Common in males

    • Well-demarcated erythematous rash in groin ± upper thighs/buttocks

  • Tinea corporis (trunk, limbs, face) – "Ringworm"

    • Annular, itchy lesions; more inflammatory if animal-derived

  • Tinea manus (hands) – Unilateral scaling of palms or ring-shaped lesions on dorsum

  • Tinea capitis (scalp)Children

    • Patchy hair loss, scaling, black dot sign (broken hairs)

    • Kerion: Painful, pustular boggy mass (severe inflammatory variant)

  • Onychomycosis (nails) – Requires separate management

    • Thickened, brittle, discoloured nails


Differential Diagnoses

  • Eczema (dermatitis): Tinea has sharper border, central clearing

  • Pityriasis rosea: Herald patch, follows skin cleavage lines

  • Granuloma annulare: Ring-like but lacks scale/itch

  • Psoriasis: Thicker scale, nail pitting, less annular

  • Candidiasis: In moist skin folds, lacks true ring pattern


Diagnosis

  • Clinical suspicion: Annular scaly lesion ± itch

  • Microscopy & culture (for confirmation before oral therapy)

    • Skin scrapings, nail clippings, plucked hairs

    • Wood lamp (fluoresces Microsporum canis)

Indications for Topical vs. Oral Therapy

  • Topical therapy: Recent onset, localised (trunk, groin, limbs, interdigital)

  • Oral therapy: Widespread, hyperkeratotic, recurrent, scalp/palm/sole involvement, treatment failure


Management


Topical Therapy (Mild, Localised Infections)

  • Terbinafine 1% cream/gel: Once/twice daily 1–2 weeks (preferred)

  • Azoles (clotrimazole, ketoconazole, miconazole, bifonazole, econazole): Once/twice daily 2–4 weeks

  • Key Points:

    • Avoid steroid-antifungal combinations (does not improve cure rates)

    • Keep feet dry, change socks, dry shoes thoroughly

    • If no improvement → reassess diagnosis or consider oral therapy


Oral Therapy (Extensive, Resistant, Hyperkeratotic, Palms/Soles, Recurrent Cases)

  • Terbinafine 250 mg daily (adults)

    • 2 weeks (corporis/cruris), 4 weeks (pedis)

    • Children: <20 kg → 62.5 mg, 20–40 kg → 125 mg

  • Fluconazole 150 mg weekly (6 weeks)

  • Itraconazole (Sporanox)

    • 100 mg daily (corporis/cruris 2 weeks, pedis 4 weeks)

    • Lozanoc capsule: 50 mg daily (same duration)

  • Griseofulvin 500 mg daily (cheaper, less effective)

    • Child: 10 mg/kg (max 500 mg) 8–12 weeks


Tinea Capitis (Scalp) – Always Requires Oral Therapy

  • Terbinafine 250 mg daily x 4 weeks (Trichophyton)

    • Children: Dose by weight

  • Griseofulvin 20 mg/kg daily x 6–8 weeks (Microsporum)

  • Alternatives:

    • Itraconazole (Sporanox liquid) 5 mg/kg daily x 4 weeks

    • Fluconazole 6 mg/kg daily (3–6 weeks) OR 8 mg/kg weekly (8–12 weeks)


Kerion (Severe Inflammatory Tinea Capitis)

  • Urgent referral

  • Treat with oral antifungals ± antibiotics (secondary infection)


Follow-Up

  • Repeat culture at end of treatment

  • If scalp clinically normal + negative culture → stop therapy

  • Persistent positive culture → continue treatment, reassess every 4–6 weeks


Bookmark Failed!

Bookmark Saved!

bottom of page